Related references
Note: Only part of the references are listed.Combined Assessment of Serum Periostin and YKL-40 May Identify Asthma-COPD Overlap
Toshihiro Shirai et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
European Journal of Internal Medicine journal homepage: Factors reducing omalizumab response in severe asthma
B. Sposato et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Oxidative stress and cellular pathways of asthma and inflammation: Therapeutic strategies and pharmacological targets
Vikas Mishra et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Baseline serum CXCL10 and IL-12 levels may predict severe asthmatics' responsiveness to omalizumab
Maho Suzukawa et al.
RESPIRATORY MEDICINE (2018)
Serum periostin is associated with body mass index and allergic rhinitis in healthy and asthmatic subjects
Hirokazu Kimura et al.
ALLERGOLOGY INTERNATIONAL (2018)
T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED
Chih-Hsi Scott Kuo et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Airway and serum biochemical correlates of refractory neutrophilic asthma
Rafeul Alam et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
A randomized multicenter study evaluating Xolair persistence of response after long-term therapy
Dennis Ledford et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Real-life Effectiveness Studies of Omalizumab in Adult Patients with Severe Allergic Asthma: Meta-analysis
Abdulaziz Alhossan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)
Serum periostin relates to type-2 inflammation and lung function in asthma: Data from the large population-based cohort Swedish GA(2)LEN
A. James et al.
ALLERGY (2017)
Gene Expression Correlated with Severe Asthma Characteristics Reveals Heterogeneous Mechanisms of Severe Disease
Brian D. Modena et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma
T. Tajiri et al.
ALLERGY (2016)
'Real-life' effectiveness studies of omalizumab in adult patients with severe allergic asthma: systematic review
I. Abraham et al.
ALLERGY (2016)
Roles of Periostin in Respiratory Disorders
Kenji Izuhara et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Reference ranges for serum periostin in a population without asthma or chronic obstructive pulmonary disease
R. Caswell-Smith et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2016)
Role of interleukin-18 in the pathophysiology of allergic diseases
Nathan L. Sanders et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
Metabolic consequences of obesity as an outside in mechanism of disease severity in asthma
Michael C. Peters et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Interleukin-18 Is Associated With Protection Against Rhinovirus-Induced Colds and Asthma Exacerbations
David J. Jackson et al.
CLINICAL INFECTIOUS DISEASES (2015)
High IFN-gamma and low SLPI mark severe asthma in mice and humans
Mahesh Raundhal et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy
Federica Novelli et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2015)
Low interleukin (IL)-18 levels in sputum supernatants of patients with severe refractory asthma
Nikoletta Rovina et al.
RESPIRATORY MEDICINE (2015)
Interleukin-18 expression, CD8(+) T cells, and eosinophils in lungs of nonsmokers with fatal asthma
Hanako Oda et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2014)
Comprehensive efficacy of omalizumab for severe refractory asthma: a time-series observational study
Tomoko Tajiri et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2014)
Development of Assay for Determining Free IgE Levels in Serum from Patients Treated with Omalizumab
Reiko Ito et al.
ALLERGOLOGY INTERNATIONAL (2014)
Exploring the Effects of Omalizumab in Allergic Asthma An Analysis of Biomarkers in the EXTRA Study
Nicola A. Hanania et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Detection of immunological biomarkers correlated with asthma control and quality of life measurements in sera from chronic asthmatic patients
Sangita P. Patil et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2011)
Omalizumab decreases IgE production in patients with allergic (IgE-mediated) asthma; PKPD analysis of a biomarker, total IgE
Philip J. Lowe et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Relationship between serum levels of interleukin-18, IgE and disease severity in patients with atopic dermatitis
M. Trzeciak et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2011)
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Bolormaa Vandanmagsar et al.
NATURE MEDICINE (2011)
The inflammasomes: molecular effectors of host resistance against bacterial, viral, parasitic, and fungal infections
Alexander Skeldon et al.
FRONTIERS IN MICROBIOLOGY (2011)
Decreases in human dendritic cell-dependent TH2-like responses after acute in vivo IgE neutralization
John T. Schroeder et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
The IL-1 family: regulators of immunity
John E. Sims et al.
NATURE REVIEWS IMMUNOLOGY (2010)
A Functional Polymorphism in IL-18 Is Associated with Severity of Bronchial Asthma
Michishige Harada et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE-mediated) asthma
Philip J. Lowe et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma
Wisam Al-Ramli et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
YKL-40 is Elevated in Morbidly Obese Patients and Declines After Weight Loss
Moritz Hempen et al.
OBESITY SURGERY (2009)
The relationship between serum levels of total IgE, IL-18, IL-12, IFN-gamma and disease severity in children with atopic dermatitis
Murat Aral et al.
MEDIATORS OF INFLAMMATION (2006)
Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance
J Hung et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005
American Thoracic Society et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Omalizumab treatment downregulates dendritic cell Fc epsilon F-RI expression
C Prussin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18
D Novick et al.
CYTOKINE (2001)
IL-18 might reflect disease activity in mild and moderate asthma exacerbation
H Tanaka et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
IL-18 induction of IgE:: dependence on CD4+ T cells, IL-4 and STAT6
T Yoshimoto et al.
NATURE IMMUNOLOGY (2000)
IFN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma
JS Wild et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
